West Oak Capital, LLC Amgen Inc Transaction History

West Oak Capital, LLC

$2.83 Billion
Q4 2024

A detailed history of West Oak Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, West Oak Capital, LLC holds 8,623 shares of AMGN stock, worth $2.43 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

8,623

Previous 8,823 2.27%

Holding current value

$2.43 Million

Previous $22.5 Million -0.0%

% of portfolio

0.8%

Previous 0.8%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$258.78 - $328.31 $51,755 - $65,662	-200 Reduced 2.27%	8,623 $22.5 Million
Q3 2024 Oct 17, 2024	SELL	$309.38 - $337.38 $40,219 - $43,859	-130 Reduced 1.45%	8,823 $28.4 Million
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $109,566 - $133,152	417 Added 4.89%	8,953 $2.8 Million
Q1 2024 Apr 18, 2024	BUY	$268.87 - $324.56 $15,863 - $19,149	59 Added 0.7%	8,536 $2.43 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $65,203 - $73,557	-255 Reduced 2.92%	8,477 $2.6 Million
Q3 2023 Oct 05, 2023	BUY	$218.65 - $271.46 $68,218 - $84,695	312 Added 3.71%	8,732 $2.35 Million
Q2 2023 Jul 19, 2023	SELL	$214.27 - $253.37 $118,919 - $140,620	-555 Reduced 6.18%	8,420 $1.87 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $66,608 - $81,184	295 Added 3.4%	8,975 $2.17 Million
Q4 2022 Jan 05, 2023	SELL	$229.03 - $291.01 $88,176 - $112,038	-385 Reduced 4.25%	8,680 $2.28 Million
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $8,978 - $10,126	-40 Reduced 0.44%	9,065 $2.04 Million
Q2 2022 Jul 11, 2022	SELL	$230.71 - $256.74 $56,985 - $63,414	-247 Reduced 2.64%	9,105 $2.22 Million
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $6,578 - $7,277	30 Added 0.32%	9,352 $2.26 Million
Q4 2021 Jan 12, 2022	SELL	$198.88 - $227.6 $18,893 - $21,622	-95 Reduced 1.01%	9,322 $2.1 Million
Q3 2021 Oct 07, 2021	BUY	$212.27 - $248.7 $38,845 - $45,512	183 Added 1.98%	9,417 $2 Million
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $43,212 - $47,940	185 Added 2.04%	9,234 $2.25 Million
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $15,533 - $18,102	70 Added 0.78%	9,049 $2.25 Million
Q4 2020 Jan 08, 2021	BUY	$216.38 - $257.67 $86,552 - $103,068	400 Added 4.66%	8,979 $2.06 Million
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $149,941 - $166,747	-639 Reduced 6.93%	8,579 $2.18 Million
Q2 2020 Jul 06, 2020	SELL	$197.81 - $242.74 $44,507 - $54,616	-225 Reduced 2.38%	9,218 $2.17 Million
Q1 2020 Apr 07, 2020	BUY	$182.24 - $241.7 $17,130 - $22,719	94 Added 1.01%	9,443 $1.91 Million
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $197,346 - $253,657	-1,043 Reduced 10.04%	9,349 $2.25 Million
Q3 2019 Oct 02, 2019	SELL	$174.11 - $208.62 $73,996 - $88,663	-425 Reduced 3.93%	10,392 $2.01 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $128,358 - $150,465	770 Added 7.66%	10,817 $1.99 Million
Q1 2019 Apr 03, 2019	BUY	$180.87 - $203.88 $13,565 - $15,291	75 Added 0.75%	10,047 $1.91 Million
Q4 2018 Jan 08, 2019	SELL	$178.4 - $208.25 $1,427 - $1,666	-8 Reduced 0.08%	9,972 $1.94 Billion
Q3 2018 Oct 04, 2018	BUY	$185.29 - $208.89 $7,411 - $8,355	40 Added 0.4%	9,980 $2.07 Billion
Q2 2018 Jul 06, 2018	SELL	$166.05 - $186.51 $651,746 - $732,051	-3,925 Reduced 28.31%	9,940 $1.83 Billion
Q1 2018 Apr 05, 2018	BUY	$169.43 - $198.0 $679,753 - $794,376	4,012 Added 40.72%	13,865 $2.36 Billion
Q4 2017 Jan 05, 2018	SELL	$168.79 - $188.59 $28,694 - $32,060	-170 Reduced 1.7%	9,853 $1.71 Billion
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $1.68 Million - $1.91 Million	10,023	10,023 $1.87 Billion

Others Institutions Holding AMGN

# of Institutions

3,079

Shares Held

405M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Account

West Oak Capital, LLC Amgen Inc Transaction History